![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
A recent study by Kampa et al. provided further evidence of nongenomic, membrane-initiated estrogen signaling. Using a cell-impermeable estradiol–bovine serum albumin conjugate, the authors identified genes and kinases that were modulated by a membrane-associated estrogen receptor, which they have termed ‘ERx.’ They describe how estradiol-induced ERx function is insensitive to antiestrogens tamoxifen and fulvestrant. The ERx components upregulated kinase signaling pathways and genes implicated in cancer progression, suggesting that ERx may promote antiestrogen resistance. However, the existence of membrane-initiated estrogen signaling and its contribution to antiestrogen resistance in vivo await confirmation.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.